• Protein A/G Magnetic Beads for Pathway Validation

  2026-08-26

  Protein A/G Magnetic Beads provide a low-background route to antibody purification, immunoprecipitation, and interaction mapping. This article shows how recombinant Protein A and Protein G beads can help translate the acacetin–MAPK1/HMOX1 findings in intervertebral disc degeneration into testable assay strategies.

• VER 155008: HSP 70 Inhibitor Assay Workflows

  2026-08-25

  Build mechanism-led biochemical, cancer-cell, and condensate assays with VER 155008 rather than relying on a single viability endpoint. This guide connects ATPase-pocket inhibition to apoptosis, client-protein instability, and HSP70-regulated TDP-43 condensate biology while emphasizing formulation, timing, and interpretation controls.

• Carvedilol Phosphate: From GPCR Signals to Hepatic IRI

  2026-08-25

  A translational framework for using Carvedilol Phosphate to interrogate beta-adrenergic signaling, hepatocyte–macrophage crosstalk, and ischemia–reperfusion injury without overstating what current evidence proves.

• Carbenoxolone disodium: Practical Lab Guide

  2026-08-24

  Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor used to perturb glucocorticoid handling, corticosterone metabolism, and gap junction communication in controlled cell and tissue experiments. It is suitable for mechanistic screening with appropriate controls, but it should not be treated as a selective target-validation reagent or as an in vivo efficacy compound without additional validation.

• Artesunate: From Viability Signal to Cell Death

  2026-08-24

  Artesunate is an artemisinin derivative whose cancer activity should be interpreted through more than a single viability endpoint. This guide combines mechanism-focused assay design with the relative-versus-fractional viability framework from a doctoral cancer biology study.

• Tumor-Targeted PAD4 Inhibitors and NETs

  2026-08-23

  The reference study developed phenylboronic acid–modified PAD4 inhibitors, identifying Compound 5i as a lead that links tumor targeting with suppression of the PAD4–H3cit–NET pathway. Across sarcoma and breast cancer models, the compound reduced tumor growth and metastasis while altering the tumor immune microenvironment, providing a preclinical framework for more selective PAD4 inhibition.

• Ertapenem (sodium salt) for Reliable Assays

  2026-08-22

  This scenario-driven guide explains how Ertapenem (sodium salt), SKU C3451, can support contamination control, antibiotic-resistance research, and interpretable cell-based workflows. It covers mechanism, solvent compatibility, concentration planning, data interpretation, and practical vendor selection using product data and recent CREC literature.

• Pifithrin-α (PFTα): Reliable p53 Assays

  2026-08-22

  This scenario-based guide shows how Pifithrin-α (PFTα), SKU A4206, can help distinguish p53-dependent apoptosis, growth arrest, and ferroptosis in cell-based experiments. It combines literature context with practical solvent, storage, control, and vendor-selection guidance for more interpretable viability and cytotoxicity data.

• 5-(N,N-dimethyl)-Amiloride in Endothelial Assays

  2026-08-21

  5-(N,N-dimethyl)-Amiloride hydrochloride is a selective Na+/H+ exchanger probe for connecting intracellular pH regulation with endothelial barrier injury. This article develops an assay framework that distinguishes causal ion-transport effects from moesin-associated inflammatory biomarkers.

• Chicken Gasdermins Reveal New Routes to Pyroptosis

  2026-08-20

  The reference study identifies chicken GSDMA and GSDME as functional gasdermins and maps their activation by distinct caspases. Its combination of cleavage-site analysis, cell-based membrane injury assays, antibacterial testing, and chicken infection models expands pyroptosis research beyond mammalian systems and provides a framework for testing caspase-dependent inflammatory cell death in birds.

• Piroxicam and Deracoxib in Canine Mammary Cancer

  2026-08-20

  This 2012 study examined whether piroxicam and deracoxib directly suppress growth of the canine mammary carcinoma cell line CMT-U27, either alone or in combination. Using MTT viability testing and flow cytometry, the authors found stronger growth inhibition, apoptosis, and G0/G1 accumulation with combined treatment, while also highlighting the need to distinguish in vitro activity from clinically achievable exposure.

• GDC-0994: Reading ERK Signals in Liver Models

  2026-08-19

  GDC-0994 is an ERK1/2 inhibitor that can convert pathway biology into a layered assay strategy spanning tumor models and cholestatic liver research. This article explains how to distinguish target engagement, bile-flow phenotypes, and causal rescue without overstating what zebrafish or preclinical data can prove.

• Penicillin G Sodium: Applied Lab Workflows

  2026-08-19

  Build reproducible susceptibility, time-kill, contamination-control, and infected-cell assays around Penicillin G Sodium rather than relying on a single endpoint. This guide combines mechanism-led experimental design with orthogonal readouts and practical troubleshooting for penicillinase-sensitive organisms.

• Calpain Inhibitor I, ALLN: Practical Lab Guide

  2026-08-18

  Calpain Inhibitor I, ALLN (SKU A2602) provides a research tool for probing calpain- and cathepsin-associated proteolysis in apoptosis assays, inflammation research, and ischemia-reperfusion injury models. It is water-insoluble, requires controlled solvent preparation, and should not be used as a diagnostic, therapeutic, or exclusively calpain-specific reagent.

• Ampicillin sodium: Assays, Workflows & Troubleshooting

  2026-08-18

  Ampicillin sodium combines a defined β-lactam mechanism with practical utility in susceptibility testing, recombinant selection, and antibiotic resistance research. This guide connects broth dilution principles with workflow-level controls, comparative assay design, and troubleshooting strategies for more reproducible antibacterial studies.

8045 records 1/537 page Next 12345 下5页 Last page